ArticleFrontiers in immunology2024

Comparison of lenvatinib plus pembrolizumab versus first-line systemic chemotherapy for advanced intrahepatic cholangiocarcinoma: a real-world retrospective study.

Zhenyun Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.